Position in XENE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$28,818,616
+$17,434,247 QoQ
Shares Held
495,591
+95.1% QoQ
Ownership
0.513%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
10 quarters on record
Voting authority
Sole 50.ToString("F0")%
Shared 50.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Derivatives in XENE
reported options exposure · as of Mar 31, 2026CallValue
$2,756,310
CallShares
47,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026TUDOR INVESTMENT CORP ET AL holds $331,863,418 across 116 Biotechnology names. XENE ranks #3 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
462,588 | $53,114,354 | |
| 2 | RPRX |
Royalty Pharma plc
|
671,680 | $32,220,489 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
This page
|
495,591 | $28,818,616 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
650,000 | $26,149,500 | |
| 5 | TERN |
Terns Pharmaceuticals, Inc.
|
267,520 | $14,103,654 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
900,000 | $13,014,000 | |
| 7 | ABVX |
Abivax S.A.
|
101,611 | $11,314,384 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
87,852 | $8,543,607 |
All Filings in XENE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,818,616 | 495,591 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $2,756,310 | 47,400 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $11,384,369 | 254,002 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $313,740 | 7,000 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $3,084,483 | 76,824 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $1,236,620 | 30,800 | Put | Defined | 2025-11-14 | |
| 2024-12-31 | $339,903 | 8,671 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,444,367 | 36,687 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $983,795 | 25,232 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,083,008 | 25,157 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,990,759 | 43,221 | Shares | Defined | 2024-02-14 | |
| 2023-03-31 | $1,070,407 | 29,908 | Shares | Defined | 2023-05-15 | |
| 2022-06-30 | $618,621 | 20,336 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||